Johnson & Johnson halts mid-stage trial of experimental eczema drug
Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
Eli Lilly hits $1 trillion market value, first for health care company
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
Metsera calls Novo Nordisk’s new bid superior to Pfizer offer
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
AMD and Palantir set to report in another busy week
Another busy week of earnings lies ahead. About 130 S & P 500 companies are set to report…
Why an Old Multiple Sclerosis Drug Costs More Than Ever in the US
When Jean Kay started a brand-new multiple sclerosis treatment called Rebif in 2003, it cost $17,500 a year.…
What’s likely to move the market in the next trading session
Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…
Trump, Pfizer to announce agreement to lower Medicaid drug prices
U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in…
Wall Street rises to its first gain in 4 days
NEW YORK (AP) — U.S. stocks climbed Friday and trimmed their losses for the week after a report…
Stock market today: Live updates
Traders work at the New York Stock Exchange on July 30, 2025. NYSE Stock futures were slightly higher…